申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US05256824A1
公开(公告)日:1993-10-26
The compound (-)-N-t-butyl-4,4-diphenyl-2-cyclopentenylamine, or its hydrochloride salt has anticholinergic activity, and thus has a variety of pharmaceutical utilities.
化合物(-)-N-t-叔丁基-4,4-二苯基-2-环戊烯基胺或其盐酸盐具有抗胆碱能活性,因此具有各种药物用途。